The Prostate Cancer Foundation (PCF) today announced the launch of the Hästens-PCF Global Health Award, a new initiative designed to advance equitable prostate cancer detection, diagnosis, and care in ...
LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, ...
LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) celebrated groundbreaking progress and innovation in the fight against prostate cancer at its 32 nd Annual PCF Scientific Retreat, ...
– Backed by PCF and generous donors, program has provided over $100 million in research funding to over 500 young scientists in 17 countries – The Prostate Cancer Foundation (PCF) today announced $6.3 ...
Prostate cancer survivors Mark V. Williamson and Jim East will celebrate with other men who beat the disease, Nov. 13 at the Beards and Blue Ribbons Gala. The event, which starts at 6 p.m. at The Hall ...
A new immunotherapy drug used in a prostate cancer clinical trial is showing early promise in possible treatment of the disease.
Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...
When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...
Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results